Aspire Biopharma Inc.

ASBP | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.23

-$0.49 (-5.62%)

Sep 22, 2026, 12:26 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.01M

Enterprise Value $-11.16M

Beta 0.15

Average Volume 660.57K

Shares Outstanding (Diluted) 1.04M

Shares Change YoY -15.85%

Institutional Ownership 1.70%

Exchange NASDAQ

ISIN US7389203057

Price Performance

Price Change 1M 11.9%

Price Change 3M 41.3%

Price Change 6M -74.3%

Price Change YTD -94.7%

Price Change 1Y -98.3%

Price Change 3Y -99.7%

Price Change 5Y -99.7%

1M CAGR (ann.) 12.8%

1Y CAGR (ann.) -98.3%

5Y CAGR (ann.) N/A

All-Time CAGR -80.3%

Valuation

PE Ratio -1.09

Forward PE N/A

PEG Ratio -0.01

Forward PEG -0.01

PS Ratio 10.30

Forward PS N/A

PB Ratio 0.09

P/FCF Ratio -0.14

P/Adj. FCF Ratio -0.14

P/OCF Ratio -1.26

EV/Sales -114.29

EV/EBIT 2.89

EV/EBITDA -3.65

EV/FCF 1.55

Earnings Yield -92.0%

FCF Yield -714.3%

Adj. FCF Yield -729.9%

Financial Health

Net Cash $12.17M

Total Debt $0

Cash & Short-Term Investments $12.17M

Total Assets $13.54M

Current Ratio 7.99

Quick Ratio 7.81

Debt / Equity Ratio 0.00

Debt / EBITDA 0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage -0.76

Altman Z-Score -2.84

Piotroski F-Score 5

Margins & Profitability

Gross Profit Margin 18.4%

Operating Profit Margin -7494.8%

EBITDA Margin 3367.4%

Net Profit Margin -11314.2%

FCF Margin -7358.1%

Adj. FCF Margin -7519.4%

SBC / Revenue 161.3%

SBC Impact (per share) -2.2%

Returns

Return on Assets -81.6%

Return on Equity 1993.3%

Return on Invested Capital -59.8%

Return on Capital Employed -59.8%

Return on Tangible Assets -81.6%

Historical Growth (CAGR)

Revenue CAGR 3Y 150.0%

Revenue CAGR 5Y 100.0%

Revenue CAGR 10Y N/A

EPS CAGR 3Y -10.7%

EPS CAGR 5Y -79.7%

EPS CAGR 10Y N/A

FCF CAGR 3Y -47.8%

FCF CAGR 5Y -47.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Aug 12, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-7.19M

Free Cash Flow $-7.19M

Adj. Free Cash Flow $-7.34M

FCF Per Share -$6.92

OCF Per Share -$6.92

OCF/S Ratio -7358.2%

Income Statement

Revenue $97.66K

Gross Profit $-24.45K

Operating Income $-7.32M

EBITDA $3.06M

Net Income $-11.05M

EPS (Diluted) -$8.02

Revenue / Employee $48.83K

Profit / Employee $-5.52M

Employees 2